[사회]”Beginning of the first quarter of vaccination” … announced today detailed vaccination plan



[ad_1]

[앵커]

A detailed plan for vaccination will be announced this afternoon, stating that vaccination will begin sequentially from next month starting next month.

Priority vaccination targets, vaccination institutions, vaccination administration methods, and side-effect management measures will be included.

Reporter Park Hong-gu about the report.

[기자]

The government’s goal is to start vaccination against Corona 19 in the first quarter, reach 70% of the population in the third quarter, and achieve herd immunity in November.

To this end, the government has been working on the selection of people eligible for priority vaccination.

[정은경 / 질병관리청장 (지난 11일) : 3,200만~3,600만 정도로 추정하고 구체적인 명단과 또 규모에 대한 파악을 지자체, 관계부처, 관련 협회를 통해서 받고 있는 상황입니다.]

The government plans to initiate vaccination in the order of nursing hospitals, workers in high-risk medical institutions, the elderly over 65, the chronically ill and adults under 64 years of age.

The second vaccination is also scheduled to be completed in November, the fourth quarter.

The mRNA vaccines, which are difficult to store like Pfizer and Modena, are administered at separate vaccination centers in 250 locations, including local gyms, and AstraZeneca and Janssen products are inoculated only at private medical institutions.

Special facilities, such as military and nursing homes, are run by the institution itself or by visiting a local public health facility.

To manage adverse reactions, the Korea Disease Administration and the Food and Drug Administration will establish a joint surveillance system and a dedicated harm investigation organization to determine the causality between vaccination and adverse reactions, and it will also be possible a national compensation.

[권덕철 / 보건복지부 장관 : 크고 작은 부작용이 발생합니다. 이때 과학적이고 근거 있는 자료를 가지고 의료계와 함께 국민들께 소상히 잘 설명하고…]

Currently, the government has signed a 56 million person purchase contract with global pharmaceutical companies, and the 20 million person contract with NovaVax is also in the final stage.

Although the quantity of insured vaccine is assessed as sufficient, the supply shortage is deepening worldwide, and the efficacy of the mutant virus, etc., is questioned.

This is YTN Park Hong-gu.

※ ‘Your report becomes news’ YTN is waiting for your valuable report.
[카카오톡] Search YTN to add a channel [전화] 02-398-8585 [메일] [email protected] [온라인 제보] www.ytn.co.kr

[저작권자(c) YTN & YTN plus 무단전재 및 재배포 금지]
[ad_2]